par Roumeguere, Thierry ;Verheyden, Bart;Arver, Stefan;Bitton, A;Belger, Mark;Schmitt, Henri
Référence Journal of Sexual Medicine, 5, 7, page (1708-1719)
Publication Publié, 2008-07
Référence Journal of Sexual Medicine, 5, 7, page (1708-1719)
Publication Publié, 2008-07
Article révisé par les pairs
Titre: |
|
Auteur: | Roumeguere, Thierry; Verheyden, Bart; Arver, Stefan; Bitton, A; Belger, Mark; Schmitt, Henri |
Informations sur la publication: | Journal of Sexual Medicine, 5, 7, page (1708-1719) |
Statut de publication: | Publié, 2008-07 |
Sujet CREF: | Sciences bio-médicales et agricoles |
Mots-clés: | Erectile dysfunction |
Phosphodiesterase type 5 inhibitors | |
Tadalafil | |
Treatment continuation | |
MeSH keywords: | Adult |
Aged | |
Aged, 80 and over | |
Carbolines -- therapeutic use | |
Erectile Dysfunction -- drug therapy | |
Health Status Indicators | |
Humans | |
Male | |
Middle Aged | |
Phosphodiesterase Inhibitors -- therapeutic use | |
Prospective Studies | |
Questionnaires | |
Time Factors | |
Treatment Outcome | |
Note générale: | Clinical Trial |
Journal Article | |
Multicenter Study | |
Research Support, Non-U.S. Gov't | |
DETECT study investigators | |
SCOPUS: ar.j | |
Langue: | Anglais |
Identificateurs: | urn:issn:1743-6095 |
info:doi/10.1111/j.1743-6109.2008.00790.x | |
info:pii/JSM790 | |
info:scp/47949125230 | |
info:pmid/18331259 |